August 1, 2014
Jardiance Approved for Type 2 Diabetes
Jardiance (empagliflozin) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes, which accounts for some 90 percent of diabetes cases in the United States, the agency said Friday in a news release.
Obesity Might Slow You Down at Work
People who are obese and work in manufacturing jobs may have significantly less endurance than those who weigh less, a new research suggests.
FDA Approves New Treatment for People With COPD
Patients with the
progressive, deadly respiratory ailment known as chronic
obstructive pulmonary disease (COPD) have a new weapon to battle
the disease, the U.S. Food and Drug Administration said
Ebola Patient to Be Flown to U.S. for Treatment
An American who is
battling the Ebola virus in West Africa will be flown to the United
States for treatment over the next few days, according to staff at
Emory University Hospital in Atlanta.
Health Tip: Am I A Binge Eater?
Binge eating disorder is characterized by
regularly overeating and feeling that you have lost control of your